Data from the 2004 National Health Survey highlight important aspects of the burden of diabetes in Singapore. The need for preventing diabetes and its complications remains a topmost priority in the care of our patients. With the ever increasing armamentarium of anti-diabetic agents at our disposal, a succinct knowledge of the newer agents and their role to complement existing older therapies is needed.